Kidney Transplant:
People who have received a kidney and takes the immunosuppressant drugs with calcineurin constraints are at the 44 to 73% threshold of getting increased potassium. The risk folds to double who use Angiotensin-converting enzyme inhibitors and Angiotensin-receptor blocking medications to slow the development of chronic allograft nephropathy. Hyperkalemia in post-renal transplant is not relating to the intake of multiple therapeutic medications, and it does not cause the alteration of metabolic acidosis. On the practice of alternate medication, the risks of recurrent hyperkalemia can control.